While overexpression of CREB1 is well described in a number of cancer types including solid (e.g. melanoma, glioblastoma) and hematopoietic tumors (e.g. acute myeloid leukemia)17,18, CREB1 expression and the underlying control mechanisms are only poorly analyzed in RCC. Here, CREB1 is linked to acute myeloid leukemia.